Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Ovarian, Colorectal, or Appendiceal Cancer

Conditions:   Peritoneal Carcinomatosis;   Peritoneal Neoplasms;   Ovarian Cancer;   Ovarian Neoplasms;   Colorectal Cancer;   Colorectal Neoplasms;   Appendiceal Cancer;   Appendiceal Neoplasms Interventions:   Drug: Paclitaxel;   Drug: Nilotinib Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials